bibliographicCitation |
Zloh M, Gupta M, Parish T, Brucoli F. Novel C-3-(N-alkyl-aryl)-aminomethyl rifamycin SV derivatives exhibit activity against rifampicin-resistant Mycobacterium tuberculosis RpoBS522L strain and display a different binding mode at the RNAP β-subunit site compared to rifampicin. European Journal of Medicinal Chemistry. 2021 Dec;225():113734. doi: 10.1016/j.ejmech.2021.113734. |